Next Article in Journal
A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug–Drug Interaction Frequently Observed in Graft versus Host Disease Patients
Next Article in Special Issue
Lipid–Polymer Hybrid Nanoparticles for mRNA Delivery to Dendritic Cells: Impact of Lipid Composition on Performance in Different Media
Previous Article in Journal
Neuropilin-1 and Integrins as Receptors for Chromogranin A-Derived Peptides
Previous Article in Special Issue
Evaluation of Adjuvant Activity and Bio-Distribution of Archaeosomes Prepared Using Microfluidic Technology
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(12), 2554; https://doi.org/10.3390/pharmaceutics14122554
Action Date Notes Link
article xml file uploaded 22 November 2022 12:17 CET Original file -
article xml uploaded. 22 November 2022 12:17 CET Update -
article pdf uploaded. 22 November 2022 12:17 CET Version of Record -
article html file updated 22 November 2022 12:19 CET Original file -
article xml file uploaded 22 November 2022 13:24 CET Update -
article xml uploaded. 22 November 2022 13:24 CET Update https://www.mdpi.com/1999-4923/14/12/2554/xml
article pdf uploaded. 22 November 2022 13:24 CET Updated version of record https://www.mdpi.com/1999-4923/14/12/2554/pdf
article html file updated 22 November 2022 13:26 CET Update -
article html file updated 1 March 2023 00:15 CET Update -
article html file updated 3 March 2023 21:55 CET Update https://www.mdpi.com/1999-4923/14/12/2554/html
Back to TopTop